Targeting Hepatitis C Treatment: the Importance of Interleukin (IL)-28, BMC Medicine Reveals
1/8/2013 7:32:05 AM
A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) clearance and response to pegylated interferon-a plus ribavirin (PEG-IFN/RBV). Information about IL28B genotype could be used to provide personalized medicine and target treatment options effectively.
comments powered by